Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 26Withdrawn 7Unknown 6Terminated 4Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 4Recurrence 1Colorectal Cancer Metastatic 1Advanced Colorectal Cancer 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × aflibercept × Gastrointestinal × Clear all
NCT04810585 2021-03-23

Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

Yonsei University

Phase 4 Unknown
153 enrolled
Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT04397601 2020-05-21

ARBITRATION

National Cancer Institute, Naples

Unknown
220 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04252456 2020-02-05

DISTINCTIVE

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Phase NA Unknown
150 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT02331927 2019-09-20

PERMAD

University of Ulm

Phase 2 Unknown
150 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03923036 2019-04-22

AVOCETTE

University Hospital, Caen

Unknown
2,000 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT02624726 2019-02-22

MINOAS

Hellenic Oncology Research Group

Phase 2 Unknown
31 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡